Research

Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease

Research /

The article, “Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease”, explores innovative in vitro methods to study Krabbe disease (KD), a severe lysosomal storage disorder. Using induced pluripotent stem cells (iPSCs), the research develops human-based models that replicate key aspects of the disease, providing insights into its mechanisms and potential therapeutic approaches. […]

Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease Read More »

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy

Research /

The study publicshed in the New England Journal of Medicine titled “Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy” investigates the long-term safety of the gene therapy elivaldogene autotemcel (eli-cel) in patients with cerebral adrenoleukodystrophy (CALD). The therapy modifies patients’ own blood-forming stem cells to include a functional gene to manage CALD. However, 7 of

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy Read More »

Experiences of mothers of long-term surviving patients with cerebral adrenoleukodystrophy: a qualitative study

Research /

Experiences of mothers of long-term surviving patients with cerebral adrenoleukodystrophy: a qualitative study Overview: The study focuses on the lived experiences of mothers caring for long-term survivors of cerebral adrenoleukodystrophy (CALD), a rare genetic disorder affecting the nervous system. It employs qualitative research methods, including in-depth interviews with mothers, to gather rich, personal insights. Key

Experiences of mothers of long-term surviving patients with cerebral adrenoleukodystrophy: a qualitative study Read More »

Gene therapy shows long-term benefit for patients with Cerebral adrenoleukodystrophy (CALD)

Research /

Gene therapy shows long-term benefit for patients with Cerebral adrenoleukodystrophy (CALD) Overview: In a study published in The New England Journal of Medicine, lentiviral gene therapy using elivaldogene autotemcel (eli-cel) showed promising results in treating cerebral adrenoleukodystrophy (CALD) in boys. Over a 24-month period, 91% of participants survived without major functional disabilities, and 94% showed

Gene therapy shows long-term benefit for patients with Cerebral adrenoleukodystrophy (CALD) Read More »

Scroll to Top